486 results on '"Wattel, Eric"'
Search Results
2. Supplementary Figure 1 from An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia
3. Supplementary Figure 2 from An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia
4. Supplemental Information from HTLV-1 bZIP Factor HBZ Promotes Cell Proliferation and Genetic Instability by Activating OncomiRs
5. TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML
6. Intragenic recruitment of NF-κB drives splicing modifications upon activation by the oncogene Tax of HTLV-1
7. Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication
8. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network
9. Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
10. Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
11. Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A Single-Center Retrospective Study
12. Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
13. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
14. Chromatin Redistribution of the DEK Oncoprotein Represses hTERT Transcription in Leukemias
15. Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes
16. Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add‐on study from the Groupe Francophone des Myelodysplasies
17. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
18. Mosaicism of HTLV-1 5′ LTR CpG methylation in the absence of malignancy
19. A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations
20. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma
21. Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
22. Acute myeloid leukemia in the elderly (age 70 yr or older): long‐term survivors
23. A Chimeric Human T Cell Leukemia Virus Type I Bearing a △R Moloney-Murine Leukemia Virus Envelope Infects Mice Persistently and Induces Humoral and Cellular Immune Responses
24. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors
25. Common Human T Cell Leukemia Virus Type 1 (HTLV-1) Integration Sites in Cerebrospinal Fluid and Blood Lymphocytes of Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Indicate that HTLV-1 Crosses the Blood-Brain Barrier via Clonal HTLV-1-Infected Cells
26. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
27. Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience
28. Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
29. HTLV-1 modulates alternative splicing in CD4+ T cells in vivo
30. Cloned HTLV-1+CD4+, but not CD8+, T-cells display an oncogenic miRNome
31. Immunohistochemical and virological features of HTLV-1-associated myosites: a study of 13 patients from West Indies and Africa
32. Tax alters telomerase activity through both quantitative and qualitative hTERT transcriptional dysregulations
33. Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1
34. Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial
35. Inactivation of hTERT transcription by Tax
36. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys ( Saimiri sciureus)
37. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis
38. HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells
39. Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents
40. LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY
41. Adult T Cell Leukaemia: A Review of Established and New Treatments
42. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy
43. Prognostic impact of ABCA3expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
44. HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from death
45. A chimeric human T cell leukemia virus type I bearing a [DELTA]R Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses
46. Adult T-cell leukaemia/lymphoma-like human T-cell leukaemia virus-1 replication in infective dermatitis
47. Somatic Mutation in Human T-Cell Leukemia Virus Type 1 Provirus and Flanking Cellular Sequences During Clonal Expansion In Vivo
48. Expression of the multidrug resistance-associated protein in myelodysplastic syndromes
49. Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL)
50. Intragenic recruitment of NF-κB drives alternative splicing modifications upon activation by the viral oncogene TAX of HTLV-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.